CD1d ligands: The good, the bad and the ugly

被引:135
作者
Brutkiewicz, Randy R.
机构
[1] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
[2] Walther Canc Inst, Walther Oncol Ctr, Indianapolis, IN 46208 USA
关键词
D O I
10.4049/jimmunol.177.2.769
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The MHC class I-like CD1d glycoprotein is a member of the CD1 family of Ag-presenting molecules and is responsible for the selection of NKT cells. A number of ligands that can be presented by CD1d to NKT or other CD1d-restricted T cells have been identified. These include glycolipids from a marine sponge, bacterial glycolipids, normal endogenous glycolipids, tumor-derived phospholipids and glycolipids, and nonlipidic molecules. The presentation of many of these molecules can have immunopotentiating effects, such as serving as an adjuvant against malaria or resulting in a more rapid clearance of certain virus infections. They can also be protective in autoimmune diseases or cancer or can be deleterious. This review will highlight these ligands in a discussion of their potential use against (and role in the pathogenesis of) these diseases.
引用
收藏
页码:769 / 775
页数:7
相关论文
共 97 条
  • [31] Hayakawa Y, 2001, EUR J IMMUNOL, V31, P1720, DOI 10.1002/1521-4141(200106)31:6<1720::AID-IMMU1720>3.0.CO
  • [32] 2-U
  • [33] A phase I study of α-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer
    Ishikawa, A
    Motohashi, S
    Ishikawa, E
    Fuchida, H
    Higashino, K
    Otsuji, M
    Iizasa, T
    Nakayama, T
    Taniguchi, M
    Fujisawa, T
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (05) : 1910 - 1917
  • [34] Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide
    Jahng, A
    Maricic, I
    Aguilera, C
    Cardell, S
    Halder, RC
    Kumar, V
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (07) : 947 - 957
  • [35] CD1 and lipid antigens: intracellular pathways for antigen presentation
    Jayawardena-Wolf, J
    Bendelac, A
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (01) : 109 - 113
  • [36] CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain
    Jayawardena-Wolf, J
    Benlagha, K
    Chiu, YH
    Mehr, R
    Bendelac, A
    [J]. IMMUNITY, 2001, 15 (06) : 897 - 908
  • [37] Natural ligand of mouse CD1d1: Cellular glycosylphosphatidylinositol
    Joyce, S
    Woods, AS
    Yewdell, JW
    Bennink, JR
    De Silva, AD
    Boesteanu, A
    Balk, SP
    Cotter, RJ
    Brutkiewicz, RR
    [J]. SCIENCE, 1998, 279 (5356) : 1541 - 1544
  • [38] Natural killer T cell activation inhibits hepatitis B virus replication in vivo
    Kakimi, K
    Guidotti, LG
    Koezuka, Y
    Chisari, FV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) : 921 - 930
  • [39] Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells
    Kang, SJ
    Cresswell, P
    [J]. NATURE IMMUNOLOGY, 2004, 5 (02) : 175 - 181
  • [40] Critical role of Vα14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection
    Kawakami, K
    Yamamoto, N
    Kinjo, Y
    Miyagi, K
    Nakasone, C
    Uezu, K
    Kinjo, T
    Nakayama, T
    Taniguchi, M
    Saito, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (12) : 3322 - 3330